Cocrystal Pharma (COCP) Assets (2010 - 2026)
Cocrystal Pharma (COCP) posted Assets of $7.4 million for Q1 2026, down 23.54% sequentially from $9.7 million in Q4 2025, and down 30.33% YoY from $10.7 million in Q1 2025.
Cocrystal Pharma (COCP) Assets (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Assets for 16 years, with the latest figure at $7.4 million in Q1 2026.
- Quarterly Assets fell 30.33% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.4 million (down 30.33% YoY) and the FY2025 annual result came in at $9.7 million, down 27.82% from the prior year.
- Assets retreated to $7.4 million in Q1 2026 per COCP's latest filing, from $9.7 million in the prior quarter.
- Over five years, Assets peaked at $75.4 million in Q1 2022 and troughed at $7.4 million in Q1 2026.
- A 5-year average of $28.0 million and a median of $26.5 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets soared 39.96% in 2022, then tumbled 60.58% in 2025.
- Over 5 years, Assets stood at $40.8 million in 2022, then slipped by 23.46% to $31.3 million in 2023, then plunged by 56.95% to $13.5 million in 2024, then decreased by 27.82% to $9.7 million in 2025, then dropped by 23.54% to $7.4 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $7.4 million, $9.7 million, and $10.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 19.82 Bn |
| 10 | Cocrystal Pharma | 16.13 Mn | 13.81 Mn | - | 4.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.65 Mn |
| Mar 31, 2026 | 7.43 Mn |
| Dec 31, 2025 | 9.71 Mn |
| Sep 30, 2025 | 10.45 Mn |
| Jun 30, 2025 | 8.51 Mn |
| Mar 31, 2025 | 10.66 Mn |
| Dec 31, 2024 | 13.46 Mn |
| Sep 30, 2024 | 16.23 Mn |
| Jun 30, 2024 | 21.57 Mn |
| Mar 31, 2024 | 26.55 Mn |
| Dec 31, 2023 | 31.26 Mn |
| Sep 30, 2023 | 32.61 Mn |
| Jun 30, 2023 | 36.28 Mn |
| Mar 31, 2023 | 37.84 Mn |
| Dec 31, 2022 | 40.84 Mn |
| Sep 30, 2022 | 45.65 Mn |
| Jun 30, 2022 | 52.38 Mn |
| Mar 31, 2022 | 75.37 Mn |
| Dec 31, 2021 | 79.39 Mn |
| Sep 30, 2021 | 82.60 Mn |